Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.985
-0.135 (-6.37%)
Apr 25, 2025, 11:22 AM EDT - Market open

Compass Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Net Income
-49.38-42.49-39.23-82.18-29.5
Upgrade
Depreciation & Amortization
1.751.891.91.622.4
Upgrade
Loss (Gain) From Sale of Assets
---0.07-0.040.28
Upgrade
Asset Writedown & Restructuring Costs
---50.62-
Upgrade
Loss (Gain) From Sale of Investments
-1.65-3.23-0.8--
Upgrade
Stock-Based Compensation
8.566.125.334.034.02
Upgrade
Other Operating Activities
---0.040.65
Upgrade
Change in Accounts Payable
-1.840.712.52-0.190.43
Upgrade
Change in Other Net Operating Assets
-2.3-3.62-3.786.44-5.08
Upgrade
Operating Cash Flow
-44.86-40.62-34.13-19.67-26.8
Upgrade
Capital Expenditures
-0.04-0.03-0.21-1.89-0.11
Upgrade
Sale of Property, Plant & Equipment
--0.180.120.14
Upgrade
Investment in Securities
46.8227-151.16--
Upgrade
Investing Cash Flow
46.7726.97-151.2-1.770.04
Upgrade
Long-Term Debt Repaid
----9.38-5.63
Upgrade
Net Debt Issued (Repaid)
----9.38-5.63
Upgrade
Issuance of Common Stock
18.113.1976.25128.2760.48
Upgrade
Repurchase of Common Stock
-0.23-0.16---
Upgrade
Other Financing Activities
-0.54-0.09-0.5-0.28-6.32
Upgrade
Financing Cash Flow
17.342.9475.76118.6148.54
Upgrade
Net Cash Flow
19.26-10.72-109.5797.1821.77
Upgrade
Free Cash Flow
-44.9-40.65-34.34-21.55-26.91
Upgrade
Free Cash Flow Margin
-5282.23%----
Upgrade
Free Cash Flow Per Share
-0.33-0.32-0.33-0.34-0.87
Upgrade
Cash Interest Paid
---0.370.85
Upgrade
Levered Free Cash Flow
-27.8-25.2-19.17-8.46-14.95
Upgrade
Unlevered Free Cash Flow
-27.8-25.2-19.17-8.23-14.38
Upgrade
Change in Net Working Capital
2.681.710.16-7.553.31
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q